The percentage of Shh +  cells in progressive metastatic patients was (2.12%) compared to operable tumor patients (n = 29) [0.70%] (Fig. 5D) suggesting a higher degree of circulating tumor cells. The gene discussed is SHH; the disease is neoplasm.